Study to Investigate Safety and Tolerability of a Single Dose of AZD6482

Clinical trial NCT00688714 · COMPLETED

Trial details

NCT number: NCT00688714
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Antiplatelet Effect

Start date: 2008-01-01
Primary completion: 2008-05-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.